Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
Molecular and Clinical Oncology · 12.10.2023 · 19 (6)
DOI: 10.3892/mco.2023.2691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 12.10.2023. Verfasst von Rayansh Poojary und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807-3260, USA.
Förderung
- NCI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Poojary, R., Song, A. F., Song, B. S., Song, C. S., Wang, L., & Song, J. (2023). Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review). Molecular and Clinical Oncology, 19(6). https://doi.org/10.3892/mco.2023.2691
Vancouver
Poojary R, Song AF, Song BS, Song CS, Wang L, Song J. Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review). Molecular and Clinical Oncology. 2023;19(6). doi:10.3892/mco.2023.2691
BibTeX
@article{Poojary2023,
author = {Poojary, Rayansh and Song, Andy Fang and Song, Benny Shone and Song, Carly Shaw and Wang, Liqing and Song, Jianxun},
title = {Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)},
journal = {Molecular and Clinical Oncology},
year = {2023},
volume = {19},
number = {6},
doi = {10.3892/mco.2023.2691}
}
EUVIMED